Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay

Bioorganic & Medicinal Chemistry Letters
2016.0

Abstract

A fluorescence-based cellular assay system was established to identify potential epigenetic modulator ligands. This assay method is to detect the de-repression of an EGFP reporter in cancer cells by the treatment of HDAC (histone deacetylase) or DNMT (DNA methyltransferase) inhibitor. Using this system, we conducted a preliminary screening of in-house natural product library containing extracts and pure compounds, and identified several active compounds. Among them, novel quinic acid derivatives were recognized as excellent HDAC inhibitors by both enzymatic and cell-based HDAC assays.

Knowledge Graph

Similar Paper

Identification of new quinic acid derivatives as histone deacetylase inhibitors by fluorescence-based cellular assay
Bioorganic & Medicinal Chemistry Letters 2016.0
Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry 2015.0
Development of a fluorescence polarization based assay for histone deacetylase ligand discovery
Bioorganic & Medicinal Chemistry Letters 2008.0
Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors
Bioorganic & Medicinal Chemistry 2023.0
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies
Bioorganic & Medicinal Chemistry 2009.0
Novel amide derivatives as inhibitors of histone deacetylase: Design, synthesis and SAR
European Journal of Medicinal Chemistry 2009.0
Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors
Bioorganic & Medicinal Chemistry 2010.0
Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors
European Journal of Medicinal Chemistry 2017.0
Fluorescent analogs of peptoid-based HDAC inhibitors: Synthesis, biological activity and cellular uptake kinetics
Bioorganic & Medicinal Chemistry 2019.0
Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents
Bioorganic & Medicinal Chemistry Letters 2013.0